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Adverse Cardiovascular Function Secondary to Inappropriate
Exogenous Androgenic Anabolic Steroid Usage in Young Adult Males
Nicholle Rothengass, PA-S
Abstract
• In today’s society body image and athletic performance are emphasized and
influenced by peers’ perception. The inappropriate use of AAS in young
males has steadily increased over the past few decades. The purpose of this
study is to determine the long-term effects AAS have upon the cardiovascular
system. The review of literature will explore studies that identify long-term
abuse of injected AAS, which are used by adult male athletes’ ages 18-40
compared to those equivalent male athletes who have never used any form
of drugs or steroids and their effects on the cardiovascular system. The
researcher plans to analyze the data of these studies to better determine how
to diagnosis, detect and educate those patients who are susceptible to injury
due to AAS usage. The research findings indicated that there is a direct
correlation between AAS and young athletic males. Several research studies
found a direct correlation between the usage of exogenous steroids and
severe cardiovascular effects within the same age group of athletes. The data
indicated that providers need to be aware of the increase in AAS users among
the younger generation. With a strong emphasize on an athletic males ability
to perform one sport to the highest level along with displaying an ideal body
image that society demands has been found to have an increase in AAS
abuse among this population. The identification and education of patients at
risk for or who are abusing AAS is crucial to prevent irreversible
cardiovascular events and/or dysfunctions from occurring secondary to
abuse.

Introduction
According to surveys and media reports, the legal and illegal inappropriate use
of anabolic-androgenic steroids (AAS) in the young adult male is gaining
popularity. Anabolic androgenic steroids are synthesized from testosterone,
which is responsible for development of primary and secondary sexual
characteristics (See Figure 3). A recent survey indicated that there are as many
as 3 million AAS users in the United States alone, and of those 3 million, 2.7%2.9% are American adolescents who have experimented at least once during
their lifetime (Evans, 2004). Evans (2004) found that only 15%-30%
inappropriate use of AAS in the young adult male in the community attend
gyms, and health clubs, and are weight-based trainers or athletes. However
two/thirds of those individuals are noncompetitive recreational body builders or
non-athletes who have strictly utilized AAS for cosmetics and to obtain the
perfect body image and increase libido, see figure 1(Evans, 2004). In a society
where athletic prowess is exemplified of an individual, one’s future career and
financial income, is based upon this prowess. This pressure directly correlated
with the increase in the utilization of AAS in young male athletes
Sachtleben,1993.

Statement of the Problem
• In young adult male athletes what effects does the long-term use of anabolic
androgenic steroids have upon the cardiovascular system?
Figure 1: Anabolic Steroids (Evans, 2004)

Research Question

Figure 3. Pathway of Human Steroidogenesis (Walters,2003)

• Pathological AAS induced left ventricular hypertrophy, impaired diastolic
filling and arrhythmia may lead to an increased risk of myocardial infarction
and sudden death. The risk of mortality among chronic individuals who
inappropriately used AAS is reported to be 4.6 times higher than non-AAS
participants who have utilized in an inappropriate mannerism (Evans, 2004).
• Physical examination can confirm a suspicion, by observing the patient
closely during examination. In a well-muscled athlete, keep an eye open for
acne, gynecomastia and cutaneous striae in the delto-pectoral area
specifically in males with small testes, low sperm counts, high hematocrit
and hemoglobin values

• What are the long-term effects of anabolic androgenic steroids on cardiac
function?
• Inappropriate abuse of anabolic-androgenic steroids in the United States is a
growing problem and concern, what are the multiple comorbidities that can
develop from the chronic abuse?

Literature Review
• Angel and John Moores University (2013) conducted a study to investigate
the effects of AAS on the cardiac structure and function and cardiovascular
risk factors. Strength-trained participants underwent cardiovascular magnetic
resonance imaging (CMR). The data analysis determined that participants
who inappropriately used AAS had:
– Higher absolute left ventricular (LV) mass (220 ± 45 g) compared to nonanabolic androgenic steroid participants (NAAS).
– Reduced right ventricular (RV) ejection fraction (AAS 51 ± 4 % vs. NAAS
59 ± 5 %; p < 0.05)
– Significantly lower left ventricular E':A' myocardial tissue velocity ratio
[AAS 0.99(0.54) vs. NAAS 1.78(0.46) p < 0.05]
– Peak LV longitudinal strain was lower in AS users (AS -14.2 ± 2.7 % vs.
NAAS -16.6 ± 1.9 %; p < 0.05)
• Kaiskcioglu (2007) conducted a study to investigate the effects AAS usage
had upon remodeling in the right atrium and ventricle. Results of the study
were as follows:
– Systolic, diastolic and pulse pressures were significantly higher in user
athletes compared with non-user athletes
– Aortic strain percent value in user athletes was significantly less than that
of the non-user group (p = 0.02)
– Aortic stiffness index in AAS users was significantly higher than that of
NAAS (2.1 ± 1.1 vs. 3.8 ± 1.4 cm2 dyn− 1 10− 6,p = 0.01; 9.3 ± 3.7 vs.
5.9 ± 2.5, p = 0.003, respectively)
• Grace and Lane (2006) conducted a study to assess vascular stiffness and
cardiac risk factors in bodybuilders using AAS. The researchers found:
– Endothelial independent dilation was significantly impaired in the AAS
group (A) compared to control groups [A (5.6 + 3.24%) vs B (11.10 +
4.91%) vs C (17.88 + 9.2%), p=0.005
• Sader (2001) conducted a cross-sectional study to examine the arterial and
cardiac structure and functions in bodybuilders who were administering
AAS to those non-steroid bodybuilders. Results of the study were as
follows:
– AAS users self-reported significant increased strength (150 ±16vs 109
±29kg, p=0.4)
– The LV mass was significantly greater compared to those non AAS
bodybuilder users, along with the arterial DMD and impaired
endothelial function (See table 1)
– LV hypertrophy, increased LV mass, cardiomyopathy and sudden death
are correlated with inappropriate AAS use
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Figure 4: Bodybuilders autopsy heart left
ventricular hypertrophy
(Sader, 2001)

Fig 2 :An anterior-posterior view of the left coronary system. The left anterior
artery demonstrates a 95% stenosis after the first septal branch (Sader,2001)
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